CompoAtlas

Femarelle Unstoppable

Natural health product licensed in Canada

Licence holder
Renu Life Sciences Inc.
NPN or DIN-HM
80125186
Status
Active licence
Licence date
23 June 2023
Revision date
9 April 2025
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Biotine

Source : Biotine

100 MicrogrammesNot calculated
Glycine max

Source : Glycine max - Graine

Extract : Matériel brut sec

Extraction ratio : 2.632:1

Dry plant equivalent : 847.36 mg

322 mgNot calculated
Glycine max

Source : Glycine max - Graine

Extract : Matériel brut sec

Extraction ratio : 3.03:1

Dry plant equivalent : 975.5 mg

Not specifiedNot calculated
Riboflavine

Source : Riboflavine

1 mgNot calculated
Calcium

Source : Carbonate de calcium

80 mgNot calculated
Vitamine D

Source : Cholécalciférol

10 MicrogrammesNot calculated

Non-medicinal ingredients

Gélatine

PopulationAgeQuantity per servingFrequency
Population not specifiedminimum: 18 years1 Capsule2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

A factor in normal growth and development. A factor in the maintenance of good health. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). As part of a healthy diet (when taken with Vitamin D) may help prevent bone loss/osteoporosis. Contributes to maintaining general health. For maintaining general health. Helps in energy metabolism/(and) tissue formation. Helps in the absorption (and use) of calcium and phosphorus. Helps in the development and maintenance of bones/(and) teeth especially in children and young adults. Helps in the development and maintenance of bones/(and) teeth. Helps maintain/support bone health. Helps to build strong bones/(and) teeth. Helps to maintain/support healthy hair/nail/mucous membranes/(and) skin. Helps to maintain/support healthy mucous membranes. Helps to maintain/support immune function/the immune system. Helps to maintain/support normal metabolism of iron. Helps to maintain/support normal muscle function. Helps to maintain/support normal red blood cells. Helps to maintain/support the body¿s ability to metabolize nutrients. Helps to prevent biotin deficiency. Helps to prevent riboflavin deficiency. Helps to prevent vitamin D deficiency. Helps with immune function/the immune system. Maintains/supports good health. Mineral supplement. Multi-vitamin supplement. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s) to support biological functions which play a key role in the maintenance of good health. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in normal growth and development. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in the maintenance of good health. Source of/Provides (an) electrolyte(s) for the maintenance of good health. Vitamin D intake, when combined with sufficient calcium, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Vitamin and mineral supplement. Vitamin supplement. Helps relieve symptoms associated with menopause and thereby improves quality of life Helps support bone health in postmenopausal women. Helps relieve symptoms associated with menopause such as joint and muscle pain; tiredness; fatigue, painful intercourse and vaginal dryness. Helps support healthy bone mineral density (BMD) DT56a is clinically shown to help reduce symptoms associated with menopause.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80125186

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line